Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131682) titled 'Effect of Valproic Acid Serum Concentration on Survival in Patients with Glioma-Associated Epilepsy: A Single-Arm, Prospective Cohort Study' on Sept. 5.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Condition:
Epilepsy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: The high-concentration and low-concentration groups of sodium valproate:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=338...